catechol has been researched along with Alzheimer Disease in 12 studies
Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)
| Excerpt | Relevance | Reference |
|---|---|---|
| "As for Alzheimer's disease, we analyzed the effect of coffee on amyloid β (Aβ) production in human neuronal SH-SY5Y cells." | 2.66 | [Molecular Basis of Preventive Effects of Habitual Coffee Intake against Chronic Diseases]. ( Tamura, H, 2020) |
| "The number of patients with Alzheimer's disease (AD) and type 2 diabetes (T2D) is increasing rapidly, and thus more research has been focused on the relationship between these two age-related chronic diseases." | 1.56 | Inhibitory activities of phenylpropanoids from Lycopus lucidus on amyloid aggregation related to Alzheimer's disease and type 2 diabetes. ( Murata, T; Shigemori, H; Sun, J, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 4 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Velander, P | 1 |
| Wu, L | 1 |
| Hildreth, SB | 1 |
| Vogelaar, NJ | 1 |
| Mukhopadhyay, B | 1 |
| Helm, RF | 1 |
| Zhang, S | 1 |
| Xu, B | 1 |
| Sun, J | 1 |
| Murata, T | 1 |
| Shigemori, H | 4 |
| Tamura, H | 2 |
| Tsunoda, T | 1 |
| Takase, M | 2 |
| Fukuyama, K | 1 |
| Kakio, S | 1 |
| Nakazawa, Y | 1 |
| Kobata, K | 1 |
| Funakoshi-Tago, M | 1 |
| Suzuki, T | 1 |
| Jiang, G | 1 |
| Aihara, Y | 1 |
| Kurisu, M | 1 |
| Miyamae, Y | 1 |
| Murakami, K | 1 |
| Han, J | 1 |
| Isoda, H | 1 |
| Irie, K | 1 |
| Soloway, AH | 1 |
| Soloway, PD | 1 |
| Warner, VD | 1 |
| Soeda, Y | 1 |
| Yoshikawa, M | 1 |
| Almeida, OF | 1 |
| Sumioka, A | 1 |
| Maeda, S | 1 |
| Osada, H | 1 |
| Kondoh, Y | 1 |
| Saito, A | 1 |
| Miyasaka, T | 1 |
| Kimura, T | 1 |
| Suzuki, M | 1 |
| Koyama, H | 1 |
| Yoshiike, Y | 1 |
| Sugimoto, H | 1 |
| Ihara, Y | 1 |
| Takashima, A | 1 |
| Sugimoto, K | 1 |
| Tamura, K | 1 |
| Ohta, N | 1 |
| Tohda, C | 1 |
| Toyooka, N | 1 |
| Nemoto, H | 1 |
| Matsuya, Y | 1 |
| da Silva, GF | 1 |
| Ming, LJ | 1 |
| Fornstedt, B | 1 |
2 reviews available for catechol and Alzheimer Disease
| Article | Year |
|---|---|
[Molecular Basis of Preventive Effects of Habitual Coffee Intake against Chronic Diseases].
Topics: Adipogenesis; Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animal | 2020 |
Role of catechol autooxidation in the degeneration of dopamine neurons.
Topics: Aged; Alzheimer Disease; Animals; Brain; Catechols; Dementia; Dopamine; Guinea Pigs; Humans; Nerve D | 1990 |
10 other studies available for catechol and Alzheimer Disease
| Article | Year |
|---|---|
Catechol-containing compounds are a broad class of protein aggregation inhibitors: Redox state is a key determinant of the inhibitory activities.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloidogenic Proteins; Animals; Anthraquinones; Catechols | 2022 |
Inhibitory activities of phenylpropanoids from Lycopus lucidus on amyloid aggregation related to Alzheimer's disease and type 2 diabetes.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Catechols; Diabetes Mellitus, Type 2; Humans; Islet Amyloi | 2020 |
Structure-activity relationship of clovamide and its related compounds for the inhibition of amyloid β aggregation.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Cacao; Catechols; Cinnamates; Dihydroxyphenylalanine; Huma | 2018 |
Roasted Coffee Reduces β-Amyloid Production by Increasing Proteasomal β-Secretase Degradation in Human Neuroblastoma SH-SY5Y Cells.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Aspartic Acid Endope | 2018 |
Inhibitory activities of kukoamines A and B from Lycii Cortex on amyloid aggregation related to Alzheimer's disease and type 2 diabetes.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Caffeic Acids; Catechols; Diabetes Mellitus, Type 2; Human | 2020 |
Inhibition of amyloid β aggregation by acteoside, a phenylethanoid glycoside.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Catechols; Dose-Response Relationship, Drug; Glucosides; H | 2013 |
Possible chemical initiators of cognitive dysfunction in phenylketonuria, Parkinson's disease and Alzheimer's disease.
Topics: Alzheimer Disease; Catechols; Cognition Disorders; Humans; Metabolic Networks and Pathways; Methioni | 2013 |
Toxic tau oligomer formation blocked by capping of cysteine residues with 1,2-dihydroxybenzene groups.
Topics: Adrenergic beta-Agonists; Alzheimer Disease; Animals; Behavior, Animal; Blotting, Western; Brain; Ca | 2015 |
Synthesis of dihydrofuran-fused perhydrophenanthrenes having a phenolic hydroxyl group as a novel anti-Alzheimer's disease agent.
Topics: Alzheimer Disease; Catechols; Chemistry, Pharmaceutical; Drug Design; Humans; Models, Chemical; Mole | 2012 |
Metallo-ROS in Alzheimer's disease: oxidation of neurotransmitters by CuII-beta-amyloid and neuropathology of the disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Catecholamines; Catechols; Cations, Divalent; Copper; Dopa | 2007 |